Amyris Inc (STU:3A01)
€ 0.055 0 (0%) Market Cap: 692,000.00 Enterprise Value: 951.03 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Amyris Inc at Morgan Stanley Global Ingredients Conference (Virtual) Transcript

May 18, 2021 / 03:00PM GMT
Release Date Price: €10.46 (+4.76%)
Lisa Hortense Maria De Neve
Morgan Stanley, Research Division - Equity Analyst

Welcome to the Amyris fireside chat. I have John Melo, Chief Executive Officer of Amyris, here with me. I will now pass on the word to him and after that we can jump into the Q&A. John, the floor is yours.

John G. Melo
Amyris, Inc. - President, CEO & Director

Great, Lisa, first of all, thank you for having us on. It's great to be with everyone. I thought I might share a little bit about Amyris and what we do before getting into the Q&A. At Amyris, we're the world's leading synthetic biology platform. We focus on that platform being applied through, really, a series of different end markets. And the way to think about it is, we're very focused in beauty in a direct-to-consumer business that has one of the leading brand portfolios in the world, which we can describe.

And then secondly, we're able to provide ingredients to some of the world's leading companies, really to help supply the growing demand, the growing consumer shift, to sustainable, clean ingredients

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot